ArticleThe Journal of infection2023

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.

Haoting Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.